» Articles » PMID: 35942174

MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma

Overview
Date 2022 Aug 9
PMID 35942174
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Glioblastoma is one of the most common malignant tumors in the brain, and these glioblastoma patients have very poor prognosis. Ferroptosis is involved in the progression of various tumors, including the glioblastoma. This study aims to determine the involvement of microRNA (miR)-147a in regulating ferroptosis of glioblastoma in vitro.

Methods: Human glioblastoma cell lines were transfected with the inhibitor, mimic and matched negative controls of miR-147a in the presence or absence of ferroptotic inducers. To knock down the endogenous solute carrier family 40 member 1 (SLC40A1), cells were transfected with the small interfering RNA against SLC40A1. In addition, cells with or without the miR-147a mimic treatment were also incubated with temozolomide (TMZ) to investigate whether miR-147a overexpression could sensitize human glioblastoma cells to TMZ chemotherapy in vitro.

Results: We found that miR-147a level was decreased in human glioblastoma tissues and cell lines and that the miR-147a mimic significantly suppressed the growth of glioblastoma cells in vitro. In addition, miR-147a expression was elevated in human glioblastoma cells upon erastin or RSL3 stimulation. Treatment with the miR-147a mimic significantly induced ferroptosis of glioblastoma cells, and the ferroptotic inhibitors could block the miR-147a mimic-mediated tumor suppression in vitro. Conversely, the miR-147a inhibitor prevented erastin- or RSL3-induced ferroptosis and increased the viability of glioblastoma cells in vitro. Mechanistically, we determined that miR-147a directly bound to the 3'-untranslated region of SLC40A1 and inhibited SLC40A1-mediated iron export, thereby facilitating iron overload, lipid peroxidation, and ferroptosis. Furthermore, miR-147a mimic-treated human glioblastoma cells exhibited higher sensitivity to TMZ chemotherapy than those treated with the mimic control in vitro.

Conclusion: We for the first time determine that miR-147a targets SLC40A1 to induce ferroptosis in human glioblastoma in vitro.

Citing Articles

Sophora alopecuroide - Taraxacum decoction (STD) inhibits non-small cell lung cancer via inducing ferroptosis and modulating tumor immune microenvironment.

Xiaohu O, Wang J, Qiu X, Song S, Li J, Luo S Heliyon. 2024; 10(20):e39564.

PMID: 39498069 PMC: 11532862. DOI: 10.1016/j.heliyon.2024.e39564.


Targeting ferroptosis opens new avenues in gliomas.

Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H Int J Biol Sci. 2024; 20(12):4674-4690.

PMID: 39309434 PMC: 11414377. DOI: 10.7150/ijbs.96476.


Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.

Wang H, Fleishman J, Cheng S, Wang W, Wu F, Wang Y Mol Cancer. 2024; 23(1):177.

PMID: 39192329 PMC: 11348582. DOI: 10.1186/s12943-024-02088-7.


Forms of Non-Apoptotic Cell Death and Their Role in Gliomas-Presentation of the Current State of Knowledge.

Nafe R, Hattingen E Biomedicines. 2024; 12(7).

PMID: 39062119 PMC: 11274595. DOI: 10.3390/biomedicines12071546.


Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance.

Mansuer M, Zhou L, Wang C, Gao L, Jiang Y Cell Death Dis. 2024; 15(7):522.

PMID: 39039049 PMC: 11263394. DOI: 10.1038/s41419-024-06902-4.


References
1.
Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J . The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020; 36:101619. PMC: 7330619. DOI: 10.1016/j.redox.2020.101619. View

2.
Li Y, Cao Y, Xiao J, Shang J, Tan Q, Ping F . Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death Differ. 2020; 27(9):2635-2650. PMC: 7429834. DOI: 10.1038/s41418-020-0528-x. View

3.
Wang B, Peng F, Huang W, Zhou J, Zhang N, Sheng J . Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma. Acta Pharm Sin B. 2020; 10(8):1492-1510. PMC: 7488488. DOI: 10.1016/j.apsb.2019.12.013. View

4.
Lei K, Xia Y, Wang X, Ahn E, Jin L, Ye K . C/EBPβ mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, promoting brain tumor proliferation. Redox Biol. 2020; 34:101578. PMC: 7287278. DOI: 10.1016/j.redox.2020.101578. View

5.
Biamonte F, Zolea F, Bisognin A, Di Sanzo M, Saccoman C, Scumaci D . H-ferritin-regulated microRNAs modulate gene expression in K562 cells. PLoS One. 2015; 10(3):e0122105. PMC: 4376865. DOI: 10.1371/journal.pone.0122105. View